These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17263181)

  • 41. Obstacles and opportunities in new drug development.
    Kaitin KI
    Clin Pharmacol Ther; 2008 Feb; 83(2):210-2. PubMed ID: 18202685
    [No Abstract]   [Full Text] [Related]  

  • 42. Andrew Witty: the acceptable face of big pharma? Interviewed by Rebecca Coombes.
    Witty A
    BMJ; 2013 Mar; 346():f1458. PubMed ID: 23468295
    [No Abstract]   [Full Text] [Related]  

  • 43. [Negative would be welcome. The question is whose brain child this is].
    Hakimi R
    MMW Fortschr Med; 2006 Nov; 148(44):8. PubMed ID: 17632867
    [No Abstract]   [Full Text] [Related]  

  • 44. Legislation would put drugs and other therapies to a useful test.
    Carroll J
    Manag Care; 2008 May; 17(5):12-3. PubMed ID: 18567462
    [No Abstract]   [Full Text] [Related]  

  • 45. Correcting Hatch-Waxman.
    Fernandes M
    Health Aff (Millwood); 2008; 27(3):902-3; author reply 903. PubMed ID: 18475000
    [No Abstract]   [Full Text] [Related]  

  • 46. Bashing Big Pharma.
    Van Way CW
    Mo Med; 2019; 116(2):80-82. PubMed ID: 31040484
    [No Abstract]   [Full Text] [Related]  

  • 47. Licensing deals morph to acquisitions in seller's market.
    Moran N
    Nat Biotechnol; 2007 Jun; 25(6):609-10. PubMed ID: 17557085
    [No Abstract]   [Full Text] [Related]  

  • 48. Hybridon and Aegera collaborate to develop antisense drug.
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):483-4. PubMed ID: 12382515
    [No Abstract]   [Full Text] [Related]  

  • 49. Does your corporate culture contribute to the problem?
    Desjardins RE
    Food Drug Law J; 1997; 52(2):169-71. PubMed ID: 10557554
    [No Abstract]   [Full Text] [Related]  

  • 50. Notable licensing deals in the biopharma industry in the second quarter of 2017.
    D'Souza P
    Drugs Today (Barc); 2017 Aug; 53(8):453-458. PubMed ID: 29119150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. China's deadly drug problem.
    Cyranoski D
    Nature; 2007 Apr; 446(7136):598-9. PubMed ID: 17410150
    [No Abstract]   [Full Text] [Related]  

  • 52. Licensing: pros and cons for biotech.
    Villiger R; Bogdan B
    Drug Discov Today; 2009 Mar; 14(5-6):227-30. PubMed ID: 19200456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI; Cruces E; Revel L; Serradell N; Rosa E
    Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law.
    Dinh TQ
    Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027
    [No Abstract]   [Full Text] [Related]  

  • 55. Managing organizational interfaces.
    Allen TJ
    Food Drug Law J; 1997; 52(2):173-7. PubMed ID: 10557555
    [No Abstract]   [Full Text] [Related]  

  • 56. Experiences With and Challenges Afforded by Expedited Regulatory Pathways.
    Liu S; Kesselheim AS
    Clin Pharmacol Ther; 2019 Apr; 105(4):795-797. PubMed ID: 30883712
    [No Abstract]   [Full Text] [Related]  

  • 57. Congress works to permit 'biosimilar' drugs very soon.
    Carroll J
    Manag Care; 2009 Apr; 18(4):7-8. PubMed ID: 19472559
    [No Abstract]   [Full Text] [Related]  

  • 58. Life sciences licensing deals in the fourth quarter of 2017: updates and trends.
    D'Souza P
    Drugs Today (Barc); 2018 Feb; 54(2):169-175. PubMed ID: 29637940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Misleading congress about drug development: Reply.
    Dimasi JA; Hansen RW; Grabowski HG
    J Health Polit Policy Law; 2008 Apr; 33(2):319-24; discussion 325-7. PubMed ID: 18325904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A dearth of new meds.
    Kaitin KI; Milne CP
    Sci Am; 2011 Aug; 305(2):16. PubMed ID: 21827111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.